UDOW ranks 2nd and PILL 21st of 30 funds in the 3x Leveraged Long Category.
PILL vs UDOW
0.8%by weight
UDOW −0.04pt a year
0.98%0.94%
UDOW 27.9×the volume
61.4K1.72M
UDOW +13.2pt
−2.5%+10.7%
PILL vs UDOW Performance
−11.9%+66.5%
- PILL 0.98%
- UDOW 0.94%, better
- PILL $16M
- UDOW $841M
- PILL +71.9%, better
- UDOW +16.0%
- PILL 0.39%
- UDOW 1.06%, better
- PILL 68
- UDOW 33
- PILL 61.4K sh
- UDOW 1.72M sh, better
- PILL $15.61
- UDOW $65.43
ETF.net Grade
| Pillar | PILL | UDOW |
|---|---|---|
| Cost | D38 | A78Higher |
| Mission | A77 | |
| Risk | C53 | A85Higher |
| Tradability | D25 | A89Higher |
| Holdings | B56 | |
| Durability | F22 | A71Higher |
Rank among 3x Leveraged Long funds
Same Category. PILL and UDOW are both graded against the same 30 3x Leveraged Long funds, so their Grades compare head to head.
Our read on each fund
PILLD
UDOWA
In short
PILL Three times the daily move of an equal-weight pharma index: not only Big Pharma, but the whole drug-development bench. 0.98% net of a waiver through September 1, 2027, and the daily reset makes it a trading tool.
UDOW The only 3x daily play on the Dow: 30 blue-chip names, price-weighted, reset every session. It is the industrial cousin of the semis-and-Nasdaq crowd that fills the leveraged aisle, and it has run since 2010.
Stated mandate
PILL The fund seeks daily investment results, before fees and expenses, equal to 300% of the performance of the S&P Pharmaceuticals Select Industry Index.
UDOW The Fund seeks daily results equal to three times the daily performance of the Dow Jones Industrial Average before fees and expenses. It uses equity securities, derivatives, and money-market instruments to pursue that daily leveraged exposure.
Why people hold it
Worth knowing
PILL vs UDOW Holdings
How PILL and UDOW differ
0.8%
Shared holdings make up 2.7% of UDOW and 0.8% of PILL.
Level by level
- Holdings0.8%
- Sector14.0%
Sector
| Sector | More in PILLMore in UDOW | PILL | UDOW |
|---|---|---|---|
| Health Care | PILL +86.0 points | 100.0% | 14.0% |
| Financials | UDOW +26.3 points | 0.0% | 26.3% |
| Technology | UDOW +19.1 points | 0.0% | 19.1% |
| Industrials | UDOW +16.0 points | 0.0% | 16.0% |
| Consumer Discretionary | UDOW +9.3 points | 0.0% | 9.3% |
| Communication | UDOW +5.2 points | 0.0% | 5.2% |
| Consumer Staples | UDOW +3.9 points | 0.0% | 3.9% |
| Materials | UDOW +3.8 points | 0.0% | 3.8% |
| Energy | UDOW +2.4 points | 0.0% | 2.4% |
Country, concentration and asset class
Country
| Country | More in PILLMore in UDOW | PILL | UDOW |
|---|---|---|---|
| United States | Same weight | 100.0% | 100.0% |
Concentration
- PILL81.1%
- UDOW68.0%
- PILL63
- UDOW32
Asset class
- PILL
- Equity
- UDOW
- Equity
Holdings
- Only in PILL61
- In both2
- Only in UDOW30
Only in PILL
61 securities, 26.8% of PILL by weight
- Goldman Finl Sq Trsry Inst 5065.65%
- Goldman Sachs Fin Gov 465 Institut1.32%
- Veradermics Inc0.59%
- Xeris Biopharma Holdings Inc0.57%
- Pacira Biosciences Inc0.52%
- Amneal Pharmaceuticals Inc0.51%
- Eli Lilly & Co0.50%
- Viatris Inc0.48%
- Maze Therapeutics Inc0.47%
- Septerna Inc0.46%
- Perrigo Co PLC0.45%
- Ligand Pharmaceuticals0.45%
- Royalty Pharma Plc- Class A0.45%
- Pfizer Inc0.44%
- Zoetis Inc0.44%
- Ani Pharmaceuticals Inc0.42%
- Indivior Pharmaceuticals Inc0.41%
- Organon & Co0.41%
- Innoviva Inc0.41%
- Collegium Pharmaceutical Inc0.41%
- Prestige Consumer Healthcare0.41%
- Definium Therapeutics Inc0.41%
- Supernus Pharmaceuticals Inc0.41%
- Elanco Animal Health Inc0.40%
- Omeros Corp0.40%
- Bristol-Myers Squibb Co0.39%
- Harmony Biosciences Holdings0.38%
- Eton Pharmaceuticals Inc0.37%
- Edgewise Therapeutics Inc0.37%
- Tarsus Pharmaceuticals Inc0.37%
- Amylyx Pharmaceuticals Inc0.36%
- Mbx Biosciences Inc0.35%
- Jazz Pharmaceuticals PLC0.35%
- Trevi Therapeutics Inc0.34%
- Amphastar Pharmaceuticals In0.33%
- Harrow Inc0.33%
- Enliven Therapeutics Inc0.32%
- Corcept Therapeutics Inc0.30%
- Nuvation Bio Inc0.30%
- Zevra Therapeutics Inc0.30%
- Lb Pharmaceuticals Inc0.30%
- Alumis Inc0.29%
- Axsome Therapeutics Inc0.28%
- Wave Life Sciences Inc0.28%
- Liquidia Corp0.27%
- Phibro Animal Health Corp-A0.26%
- Ocular Therapeutix Inc0.26%
- Cormedix Inc0.26%
- Alto Neuroscience Inc0.23%
- Rapport Therapeutics Inc0.21%
Only in UDOW
30 securities, 83.5% of UDOW by weight
- Proshares Genius Mny Mkt Etf26.20%
- Goldman Sachs Group Inc5.73%
- TREASURY BILL, 0%, due 2026-12-294.14%
- Caterpillar Inc4.00%
- Microsoft Corp3.35%
- Amgen Inc2.99%
- Visa Inc-Class A Shares2.65%
- UnitedHealth Group Inc2.61%
- Travelers Cos Inc/The2.54%
- Apple Inc2.21%
- JPMorgan Chase & Co2.16%
- Sherwin-Williams Co/The2.13%
- Home Depot Inc2.11%
- American Express Co2.05%
- Alphabet Inc-Cl A1.80%
- Mcdonald's Corp1.66%
- Intl Business Machines Corp1.65%
- Amazon.com Inc1.54%
- Chevron Corp1.51%
- Salesforce Inc1.47%
- Honeywell International Inc1.40%
- NVIDIA Corp1.31%
- 3M Co1.12%
- Boeing Co/The1.10%
- Procter & Gamble Co/The1.04%
- Walmart Inc0.79%
- Walt Disney Co/The0.71%
- Cisco Systems Inc0.67%
- Coca-Cola Co/The0.60%
- Nike Inc -Cl B0.25%
Weight gaps
All 2 Holdings in both funds, largest gap first.
| Holding | More in PILLMore in UDOW | PILL | UDOW |
|---|---|---|---|
| Johnson & Johnson | UDOW +1.33 points | 0.42% | 1.75% |
| Merck & Co. Inc. | UDOW +0.55 points | 0.41% | 0.96% |
How we measure overlap
Each holding counts at its smaller weight in the two funds, summed over the full Holdings. Sector, country and asset class use the same rule on each fund’s split. Cash, FX and derivative lines stay out of the counts. Two bond funds get no overlap figure.
PILL vs UDOW Cost
Overpaying PILL vs UDOW
$658
On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.
PILL 0.98%
$18,362
UDOW 0.94%
$17,704
Cost over time
Year by year
| Year | PILL | UDOW | Overpaying |
|---|---|---|---|
| 10 | $1,729 | $1,661 | $68 |
| 20 | $6,504 | $6,260 | $244 |
| 30 | $18,362 | $17,704 | $658 |
- 0.98%PILL
- 0.94%UDOW, cheaper
- Middle half of 3x Leveraged Long funds
- Median 0.96%
UDOW 7th cheapest of 30 funds
PILL 18th cheapest of 30 funds
PILL vs UDOW Dividends
- PILL 0.39%
- UDOW 1.06%, better
- PILL $0.06
- UDOW $0.69
- PILL $0.00094
- UDOW $0.15
- PILL Sep 22, 2026
- UDOW Sep 23, 2026
- PILL Sep 29, 2026
- UDOW Sep 29, 2026
- PILL Quarterly
- UDOW Quarterly
Distribution history
PILL vs UDOW Risk
Fall from peak · 5 years
- PILL
- UDOW
Risk facts
- Volatility
- PILL 61.4%UDOW 37.2%, better
- Return per unit of risk
- PILL 0.82UDOW 0.95, better
- Worst fall
- PILL −82.0%UDOW −56.0%, better
- Market sensitivity
- PILL 1.80UDOW 2.62
Popular comparisons
- 0.98% · 0.78%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.94% · 0.78%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.98% · 0.88%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.94% · 0.88%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.98% · 0.75%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.94% · 0.75%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.